Axon Enterprise, Inc. (NASDAQ:AXON) Shares Acquired by XTX Topco Ltd

XTX Topco Ltd raised its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 14.5% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 4,686 shares of the biotechnology company’s stock after purchasing an additional 593 shares during the quarter. XTX Topco Ltd’s holdings in Axon Enterprise were worth $1,379,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. 9258 Wealth Management LLC acquired a new stake in shares of Axon Enterprise during the 4th quarter valued at approximately $204,000. Principal Securities Inc. bought a new stake in Axon Enterprise during the fourth quarter valued at $49,000. Beacon Pointe Advisors LLC acquired a new stake in shares of Axon Enterprise during the fourth quarter worth $218,000. Robeco Institutional Asset Management B.V. raised its holdings in shares of Axon Enterprise by 1,049.8% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 59,319 shares of the biotechnology company’s stock worth $153,000 after purchasing an additional 54,160 shares during the period. Finally, PNC Financial Services Group Inc. lifted its position in shares of Axon Enterprise by 11.0% in the 4th quarter. PNC Financial Services Group Inc. now owns 4,320 shares of the biotechnology company’s stock worth $1,116,000 after buying an additional 427 shares during the last quarter. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

AXON stock opened at $393.29 on Friday. The company has a 50-day simple moving average of $348.04 and a 200 day simple moving average of $317.21. The company has a market capitalization of $29.72 billion, a P/E ratio of 115.00, a PEG ratio of 10.34 and a beta of 0.94. The company has a quick ratio of 2.52, a current ratio of 2.88 and a debt-to-equity ratio of 0.35. Axon Enterprise, Inc. has a fifty-two week low of $189.12 and a fifty-two week high of $393.58.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share for the quarter, topping analysts’ consensus estimates of $1.02 by $0.18. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The company had revenue of $504.00 million during the quarter, compared to analyst estimates of $478.35 million. During the same period in the prior year, the business posted $0.80 EPS. The business’s revenue for the quarter was up 34.5% compared to the same quarter last year. Sell-side analysts predict that Axon Enterprise, Inc. will post 1.79 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on AXON. Northland Securities boosted their price objective on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “outperform” rating in a research report on Thursday, August 8th. Craig Hallum upped their target price on Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a report on Wednesday, August 7th. Needham & Company LLC reissued a “buy” rating and issued a $400.00 price target on shares of Axon Enterprise in a report on Wednesday, August 7th. Bank of America assumed coverage on Axon Enterprise in a research report on Wednesday, July 17th. They set a “buy” rating and a $380.00 price objective for the company. Finally, Robert W. Baird increased their target price on Axon Enterprise from $360.00 to $400.00 and gave the stock an “outperform” rating in a research report on Tuesday, September 10th. Two research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $365.38.

Insiders Place Their Bets

In other news, Director Michael Garnreiter sold 1,000 shares of the business’s stock in a transaction on Monday, September 16th. The stock was sold at an average price of $380.99, for a total value of $380,990.00. Following the sale, the director now owns 27,259 shares of the company’s stock, valued at approximately $10,385,406.41. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, September 16th. The shares were sold at an average price of $380.99, for a total value of $380,990.00. Following the transaction, the director now owns 27,259 shares of the company’s stock, valued at approximately $10,385,406.41. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, President Joshua Isner sold 25,811 shares of the stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $359.84, for a total transaction of $9,287,830.24. Following the sale, the president now directly owns 228,166 shares of the company’s stock, valued at $82,103,253.44. The disclosure for this sale can be found here. Insiders sold 317,981 shares of company stock worth $115,662,734 over the last ninety days. Company insiders own 6.10% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.